What is Thyrocare Technologies Price-to-Operating-Cash-Flow?
As of today (2024-05-29), Thyrocare Technologies's share price is ₹621.20.
Thyrocare Technologies's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.00. Hence, Thyrocare Technologies's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for Thyrocare Technologies's Price-to-Operating-Cash-Flow or its related term are showing as below:
NSE:THYROCARE'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 19.75 Med: 86.02 Max: 157.15
Current: 19.78
During the past 10 years, Thyrocare Technologies's highest Price-to-Operating-Cash-Flow Ratio was 157.15. The lowest was 19.75. And the median was 86.02.
Thyrocare Technologies's Cash Flow from Operations per share for the
three
months ended in Mar. 2024 was ₹0.00.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.00.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Thyrocare Technologies was 30.40% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 13.60% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 5.40% per year.
During the past 10 years, Thyrocare Technologies's highest 3-Year average Operating Cash Flow per Share Growth Rate was 41.80% per year. The lowest was -8.40% per year. And the median was 13.60% per year.
Thyrocare Technologies Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Thyrocare Technologies's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thyrocare Technologies Price-to-Operating-Cash-Flow Chart
|
Thyrocare Technologies Annual Data
|
|
Trend |
Mar15 |
Mar16 |
Mar17 |
Mar18 |
Mar19 |
Mar20 |
Mar21 |
Mar22 |
Mar23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
15.65 |
41.66 |
36.22 |
17.63 |
18.56 |
|
Thyrocare Technologies Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
17.63 |
- |
- |
- |
18.56 |
Competitive Comparison of Thyrocare Technologies's Price-to-Operating-Cash-Flow
For the Diagnostics & Research subindustry, Thyrocare Technologies's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Thyrocare Technologies's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Thyrocare Technologies's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Thyrocare Technologies's Price-to-Operating-Cash-Flow falls into.
Thyrocare Technologies Price-to-Operating-Cash-Flow Calculation
Thyrocare Technologies's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 621.20 | / | 0 |
| = | |
Thyrocare Technologies's Share Price of today is ₹621.20.
Thyrocare Technologies's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Thyrocare Technologies (NSE:THYROCARE) Business Description
Traded in Other Exchanges
Address
D-37/1, TTC Industrial Area, MIDC, Turbhe, Opposite Sandoz, Navi Mumbai, MH, IND, 400703
Thyrocare Technologies Ltd is a diagnostics & research company. The company has three business segments: Diagnostic Testing Services, Imaging Services, and Other. The Diagnostic Testing Services segment provides a medical diagnostic investigation into thyroid disorders, metabolism disorders, diabetes, anemia, infertility, auto-immunity, and other infectious diseases. The company primarily earns majority of its revenue from Diagnostic Testing Services segment. The Imaging Services segment operates a network of imaging centers focused on early and effective cancer monitoring. The Other business segment provides miscellaneous services. The company earns the vast majority of its revenue in India.
Thyrocare Technologies (NSE:THYROCARE) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSE:THYROCARE has been successfully added to your